Literature DB >> 12954564

Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection.

JoAnn M Tufariello1, John Chan, JoAnne L Flynn.   

Abstract

Most people infected with Mycobacterium tuberculosis contain the initial infection and develop latent tuberculosis. This state is characterised by evidence of an immune response against the bacterium (a positive tuberculin skin test) but no signs of active infection. It can be maintained for the lifetime of the infected person. However, reactivation of latent infection occurs in about 10% of infected individuals, leading to active and contagious tuberculosis. An estimated 2 billion people worldwide are infected with M tuberculosis--an enormous reservoir of potential tuberculosis cases. The establishment and reactivation of latent infection depend on several factors, related to both host and bacterium. Elucidation of the host immune mechanisms that control the initial infection and prevent reactivation has begun. The bacillus is well adapted to the human host and has a range of evasion mechanisms that contribute to its ability to avoid elimination by the immune system and establish a persistent infection. We discuss here current understanding of both host and bacterial factors that contribute to latent and reactivation tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12954564     DOI: 10.1016/s1473-3099(03)00741-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  125 in total

1.  The Mycobacterium tuberculosis stress response factor SigH is required for bacterial burden as well as immunopathology in primate lungs.

Authors:  Smriti Mehra; Nadia A Golden; Kerstan Stuckey; Peter J Didier; Lara A Doyle; Kasi E Russell-Lodrigue; Chie Sugimoto; Atsuhiko Hasegawa; Satheesh K Sivasubramani; Chad J Roy; Xavier Alvarez; Marcelo J Kuroda; James L Blanchard; Andrew A Lackner; Deepak Kaushal
Journal:  J Infect Dis       Date:  2012-03-07       Impact factor: 5.226

2.  Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli.

Authors:  Iris Keren; Devang Shah; Amy Spoering; Niilo Kaldalu; Kim Lewis
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

Review 3.  Update on tuberculosis and other opportunistic infections associated with drugs blocking tumour necrosis factor {alpha}.

Authors:  K L Winthrop
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

Review 4.  New insights into mathematical modeling of the immune system.

Authors:  Penelope A Morel; Shlomo Ta'asan; Benoit F Morel; Denise E Kirschner; Joanne L Flynn
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis.

Authors:  JoAnn M Tufariello; Kaixia Mi; Jiayong Xu; Yukari C Manabe; Anup K Kesavan; Joshua Drumm; Kathryn Tanaka; William R Jacobs; John Chan
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  A mycobacterial smc null mutant is proficient in DNA repair and long-term survival.

Authors:  Carolin Güthlein; Roger M Wanner; Peter Sander; Erik C Böttger; Burkhard Springer
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

7.  Elevated N-terminal pro-brain natriuretic peptide in Mycobacterium tuberculosis pulmonary infection without myocardial dysfunction.

Authors:  Simona L Bar; Naser Sayeh; Andrew P Ignaszewski
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

8.  Initiation of acquired immunity in the lungs of mice lacking lymph nodes after infection with aerosolized Mycobacterium tuberculosis.

Authors:  Suely S Kashino; Therese Vallerskog; Gregory Martens; Jolynn Troudt; Andrew Keyser; Jenny Taylor; Angelo Izzo; Hardy Kornfeld; Antonio Campos-Neto
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 9.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

10.  Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening.

Authors:  Katherine B Hisert; Meghan A Kirksey; James E Gomez; Alexandra O Sousa; Jeffery S Cox; William R Jacobs; Carl F Nathan; John D McKinney
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.